Moore Capital Trims Stake in Zimmer Biomet

Hedge fund reduces position in medical device company by 22.5% in Q3

Mar. 17, 2026 at 10:52am

Got story updates? Submit your updates here. ›

According to a recent SEC filing, Moore Capital Management LP trimmed its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 22.5% during the third quarter. The hedge fund now owns 107,545 shares of the medical equipment provider's stock, down from 138,730 shares previously.

Why it matters

Zimmer Biomet is a major player in the orthopedic device market, so changes in institutional ownership of the stock can signal shifts in investor sentiment around the company and the broader industry.

The details

Moore Capital sold 31,185 shares of Zimmer Biomet during the third quarter, reducing its stake in the company to about 0.05% of the total shares outstanding. The hedge fund cited unspecified reasons for trimming its position in the medical device maker.

  • Moore Capital filed its 13F report for the third quarter on 2026-03-17.

The players

Moore Capital Management LP

A global multi-strategy hedge fund founded by Louis Bacon in 1989.

Zimmer Biomet Holdings, Inc.

A leading global medical device company focused on musculoskeletal healthcare products and solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Moore Capital's stake in Zimmer Biomet does not necessarily signal broader concerns about the company's performance or outlook. However, it does highlight the fluidity of institutional ownership in the medical device space as funds adjust their portfolios.